🚨 Bioverge Access Fund 4 is now accepting investors! Leverage Bioverge expertise and back 15 leading healthcare startups through a single investment. Learn more and invest

Octagon Therapeutics Presentation and Q&A with CEO Isaac Stoner

Octagon Therapeutics is developing targeted small molecules with selectivity towards autoimmune diseases

Wp4c6k7snovxt1nmudnu
Wp4c6k7snovxt1nmudnu